Sunitinib Sandoz 12,5 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sunitinib sandoz 12,5 mg hard caps.

sandoz sa-nv - sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinib 12.5 mg - sunitinib

Sunitinib Sandoz 25 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sunitinib sandoz 25 mg hard caps.

sandoz sa-nv - sunitinib 25 mg - capsule, hard - 25 mg - sunitinib 25 mg - sunitinib

Sunitinib Sandoz 50 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sunitinib sandoz 50 mg hard caps.

sandoz sa-nv - sunitinib 50 mg - capsule, hard - 50 mg - sunitinib 50 mg - sunitinib

SUNITINIB SANDOZ  12.5 MG Israel - English - Ministry of Health

sunitinib sandoz 12.5 mg

novartis israel ltd - sunitinib - hard capsule - sunitinib 12.5 mg - sunitinib - sunitinib sandoz is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sunitinib sandoz is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

SUNITINIB SANDOZ  25 MG Israel - English - Ministry of Health

sunitinib sandoz 25 mg

novartis israel ltd - sunitinib - hard capsule - sunitinib 25 mg - sunitinib - sunitinib sandoz is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sunitinib sandoz is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

SUNITINIB SANDOZ  50 MG Israel - English - Ministry of Health

sunitinib sandoz 50 mg

novartis israel ltd - sunitinib - hard capsule - sunitinib 50 mg - sunitinib - sunitinib sandoz is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sunitinib sandoz is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

Sunitinib Medichem 12.5mg Hard Capsules Malta - English - Medicines Authority

sunitinib medichem 12.5mg hard capsules

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents